Hestia Insight Inc.: management transactions · United States · SEC (Form 4)

About Hestia Insight Inc.

Hestia Insight Inc. (ticker: HSTA) is a very small-cap U.S. listed company currently referenced in OTCQB materials rather than on NYSE or NASDAQ in the documents reviewed. For international investors, it should be viewed as a highly speculative microcap whose equity story is driven by corporate transformation, limited operating scale, and execution risk. The company is incorporated in Nevada and its principal office is in Las Vegas, Nevada, United States. It was originally incorporated in 2003 as Luxshmi Investments, Inc. and later changed its name to Hestia Insight Inc. in 2019. That same year, it executed a 50-for-1 reverse stock split and completed a share exchange transaction that brought Hestia Investments Inc. into the corporate structure as a wholly owned subsidiary. These milestones matter because they frame the company’s evolution from a legacy shell-like structure into an operating platform focused on advisory and AI-enabled services. Today, Hestia Insight describes itself as an AI-powered capital markets advisory and business consulting firm serving emerging growth companies. Its core offering centers on fundraising support across the full capital-raising lifecycle: pre-raise strategy, market research, financial modeling, investor materials, due diligence support, investor outreach, and ongoing investor relations. The company also provides fractional executive support, including Chief Strategy Officer and Chief Financial Officer services, which is relevant for small issuers that cannot yet support a full in-house leadership team. Through Hestia Investments Inc., management says it provides strategic consulting, medical supply sales and marketing support, and capital markets advisory services to micro-, small-, and medium-sized companies. Historically, the group also included HSTA Health Inc., doing business as Hestia Vending, with exposure to healthy food, beverage, wellness products, and smart vending. From a competitive perspective, Hestia Insight operates in a crowded and fragmented market. Its latest filings state that it competes with consulting firms, strategy boutiques, market research providers, data and benchmarking vendors, technology advisory firms, outsourcing companies, and healthcare IT-related service providers. The company’s stated competitive edge is a combination of sector specialization, relationship-driven business development, and AI-assisted service delivery. Management has repeatedly emphasized healthcare and biotech as anchor sectors, while also broadening the platform to serve emerging growth companies more generally, including clients in the United States and Asia. Recent company communications point to a strategic pivot toward artificial intelligence. In 2024, Hestia Insight announced a shift toward AI-integrated capital markets advisory services aimed at helping small public companies simplify regulatory complexity, improve investor materials, and reduce costs. That strategic repositioning is important, but investors should balance it against the risk disclosures in recent SEC filings, which highlight going-concern uncertainty and the need for additional financing. In short, HSTA is best understood as a transformation story: a U.S.-based Nevada corporation with an advisory and healthcare heritage, now trying to reposition itself as an AI-enabled service provider for emerging growth issuers.